HOME >> BIOLOGY >> NEWS
Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting

RESTON, Va. -- The potential of molecular imaging and therapy and the power of nuclear medicineand their impact on patient carewill be explored as more than 4,000 doctors, technologists, scientists and pharmacists from around the world attend SNMs 54th Annual Meeting June 26 in Washington, D.C. SNMan international, multidisciplinary society of more than 16,000 molecular imaging and nuclear medicine professionals in 78 countriesannually showcases research that promises to revolutionize health care.

"SNM has embarked on a mission to improve health care by advancing molecular imaging and therapy, and our program features an increased presence of related research," said SNM President Martin P. Sandler. "Molecular imagingthe use of state-of-the-art imaging technologies (such as PET, SPECT, MRI and others) to "photograph" biological targets or pathways in the bodyand its therapy value will be at the forefront of personalized medicine, eventually providing patient-specific information that allows tailored treatment of disease," he added.

"Nearly 2,000 scientific and technologist studies will be presented during this meeting, offering a look at molecular imaging and nuclear medicine research leading to improvements in the diagnosis and treatment of life-threatening cancer, heart disease and brain disorders," said Scientific Program Committee Chair Frederic H. Fahey. "A new feature this year is the InfoSNM program, which will allow attendees to participate in interactive computer presentations and educational offerings on the novel applications of computers and information science in molecular imaging and nuclear medicine," explained Fahey. Also new will be the Molecular Imaging Gateway, an area devoted specifically to this exciting field sponsored by the societys Molecular Imaging Center of Excellence.

"As molecular imaging becomes a significant force in clinical practice, SNM Technologist Section members will assume an expanded role in med
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
29-Mar-2007


Page: 1 2 3

Related biology news :

1. Advances in Optics for Biotechnology, Medicine and Surgery
2. Advances in Forest Threat Assessment: Applications to Forest and Rangeland Management
3. Advances in the characterisation of the oyster mushroom genes
4. ChemGenex reports successful personalized dosing of Quinamed at ASCO
5. Faster, low cost sequencing technologies needed to drive era of personalized medicine
6. Physicians face significant new liability risks with advent of personalized medicine era
7. Encouraging results from validation study of trial of personalized treatment in breast cancer
8. Computer graphics spills from milk to medicine
9. New survey documents the headaches of computerized medicine
10. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
11. Nanotechnology, medicine and bioethics

Post Your Comments:
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
(Date:2/27/2015)... FamilyFarms Group is pleased to announce its ... Farms, received the 2015 Tomorrow’s Top Producer Horizon Award. ... of 35, who has demonstrated excellence in the business ... the Tomorrow's Top Producer Horizon Award. Every year I ... Award and learning from their experiences. It is truly ...
(Date:2/27/2015)... Feb. 27, 2015  Steep Hill, the industry leader ... internationally, intends to open a full service medical cannabis ... , bringing advanced scientific tools and methodology to ... Steep Hill is currently the only laboratory licensed by ... and contaminant testing in order to meet the recently ...
(Date:2/26/2015)... Feb. 26, 2015 S&P Capital IQ (MHFI) ... Report coverage on MabVax Therapeutics Holdings Inc . ... clinical stage biotechnology company focused on the development of ... in the treatment of cancer. MabVax has discovered a ... protective immune responses generated by patients who have been ...
(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015  23andMe, ... of Kate Black as Privacy Officer and ... federal, and state privacy laws as well as health ... regulatory team, she will be responsible for reviewing, updating ... customers in the U.S. and abroad. She joined the ...
Breaking Biology Technology:Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
Cached News: